Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses
Abhik K. Banerjee, Mario R. Blanco, Emily A. Bruce, et al.
Cell (2020) Vol. 183, Iss. 5, pp. 1325-1339.e21
Open Access | Times Cited: 543

Showing 1-25 of 543 citing articles:

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Mei-Yue Wang, Rong Zhao, Lijuan Gao, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 827
COVID-19 and the human innate immune system
Joachim L. Schultze, Anna C. Aschenbrenner
Cell (2021) Vol. 184, Iss. 7, pp. 1671-1692
Open Access | Times Cited: 661
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 532
The trRosetta server for fast and accurate protein structure prediction
Zongyang Du, Hong Su, Wenkai Wang, et al.
Nature Protocols (2021) Vol. 16, Iss. 12, pp. 5634-5651
Open Access | Times Cited: 491
Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design
Brandon Malone, Nadya Urakova, Eric J. Snijder, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 21-39
Open Access | Times Cited: 371
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
Mona Khan, Seung‐Jun Yoo, Marnick Clijsters, et al.
Cell (2021) Vol. 184, Iss. 24, pp. 5932-5949.e15
Open Access | Times Cited: 328
Human genetic and immunological determinants of critical COVID-19 pneumonia
Qian Zhang, Paul Bastard, Adem Karbuz, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 587-598
Open Access | Times Cited: 315
The SARS-CoV-2 RNA–protein interactome in infected human cells
Nora Schmidt, Caleb A. Lareau, Hasmik Keshishian, et al.
Nature Microbiology (2020) Vol. 6, Iss. 3, pp. 339-353
Open Access | Times Cited: 291
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
Carly G.K. Ziegler, Vincent N. Miao, Anna H. Owings, et al.
Cell (2021) Vol. 184, Iss. 18, pp. 4713-4733.e22
Open Access | Times Cited: 277
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors
Koji Onomoto, Kazuhide Onoguchi, Mitsutoshi Yoneyama
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 539-555
Open Access | Times Cited: 275
Type I and III interferon responses in SARS-CoV-2 infection
You‐Me Kim, Eui‐Cheol Shin
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 5, pp. 750-760
Open Access | Times Cited: 253
The interferon landscape along the respiratory tract impacts the severity of COVID-19
Benedetta Sposito, Achille Broggi, Laura Pandolfi, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4953-4968.e16
Open Access | Times Cited: 234
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis
Yaara Finkel, Avi Gluck, Aharon Nachshon, et al.
Nature (2021) Vol. 594, Iss. 7862, pp. 240-245
Open Access | Times Cited: 229
CLIP and complementary methods
Markus Hafner, Maria Katsantoni, Tino Köster, et al.
Nature Reviews Methods Primers (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 221
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research
Suzannah J. Rihn, Andres Merits, Siddharth Bakshi, et al.
PLoS Biology (2021) Vol. 19, Iss. 2, pp. e3001091-e3001091
Open Access | Times Cited: 209
SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation
Lucy Thorne, Ann‐Kathrin Reuschl, Lorena Zuliani‐Alvarez, et al.
The EMBO Journal (2021) Vol. 40, Iss. 15
Open Access | Times Cited: 199
A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19
Sin Man Lam, Chao Zhang, Zehua Wang, et al.
Nature Metabolism (2021) Vol. 3, Iss. 7, pp. 909-922
Closed Access | Times Cited: 191
SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery
Justin J. Frere, Randal A. Serafini, Kerri D. Pryce, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 191
Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics
Nagarjuna R. Cheemarla, Timothy A. Watkins, Valia T. Mihaylova, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 8
Open Access | Times Cited: 181
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
Ryan A. Flynn, Julia A. Belk, Yanyan Qi, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2394-2411.e16
Open Access | Times Cited: 176
Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells
Tammy C. T. Lan, Matthew F. Allan, Lauren E. Malsick, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 160
Innate immune evasion strategies of SARS-CoV-2
Judith M. Minkoff, Benjamin R. tenOever
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 159
The SARS-CoV-2 RNA interactome
Sung‐Yul Lee, Young-Suk Lee, Yeon Choi, et al.
Molecular Cell (2021) Vol. 81, Iss. 13, pp. 2838-2850.e6
Open Access | Times Cited: 150
The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation
Antonin Tidu, Aurélie Janvier, Laure Schaeffer, et al.
RNA (2020) Vol. 27, Iss. 3, pp. 253-264
Open Access | Times Cited: 138
Page 1 - Next Page

Scroll to top